Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- 2005 Will Be a Major Turning Point: Prefectural Health Officials Meeting
February 28, 2005
- Korosho Calls For Reimbursement of Self-Injection of IFNa, Etanercept
February 28, 2005
- Cumulative Deaths in Rheumatrex-treated Patients Reach 134: Wyeth
February 28, 2005
- REGULATORY NEWS IN BRIEF
February 28, 2005
- Sankyo, Daiichi Reportedly to Consolidate This October
February 28, 2005
- Tapered Injection Needle Reduces Pain for Diabetics: Novo Nordisk
February 28, 2005
- Taisho Toyama to Unify Compensation, Promotion Systems for MRs
February 28, 2005
- 1st 3 Qtrs Business Results -1-
February 28, 2005
- Nippon Chemiphar Aims to Double GE Sales by FY2007
February 28, 2005
- 1st 3 Qtrs Business Results -2-
February 28, 2005
- Sawai Announces Revised 3-year Management Plan
February 28, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 28, 2005
- MREAC to Begin Improving Education, Training System
February 28, 2005
- BULLETIN
February 28, 2005
- REGULATORY NEWS IN BRIEF
February 21, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 21, 2005
- MONITOR
February 21, 2005
- Aiming at Acquiring "Absolute No.1" in Diagnostic Market: Mr Ogawa of RDKK
February 21, 2005
- The Society of Japanese Pharmacopoeia Seminar
February 21, 2005
- OTC NEWS IN BRIEF
February 21, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…